Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.
This article is from
The Cancer Letter
archive.
Vol. 32 No. 06 | February 17, 2006
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
White House Gives FDA Authority Over Tobacco Product Sales
August 18, 1995
TCL Archive
Study: Blood Test More Accurate Than Traditional Tumor Biopsy
April 26, 2013
TCL Archive
In Setback For Generics, Court Overturns FDA.
November 9, 2001
TCL Archive
NIH Offers Curriculum Supplements For K-12
November 5, 1999
TCL Archive
Research Contracts Branch Reorganized, Graalman On “Detail”
October 22, 1982
TCL Archive
NCI to Fund Research Collaboration At HMOs, Health Care Provider Networks
July 11, 1997